Skip to main content
Year archive

ABIVAX — 2020 filings

All 60 regulatory filings released by ABIVAX (ABVX) in 2020, sourced directly from the official regulator.

60 Filings
2020 Period
2020 filings (60)
Filing Released Lang
L'essai de phase 2b/3 d'ABX464 « miR-AGE » dans la Covid-19 déclaré « Priorité nationale de recherche » par le comité de pilotage des essais thérapeutiques du gouvernement français
Earnings Release Q2 2021
2020-12-22 French
Abivax's Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government's Clinical Trial Council
Legal Proceedings Report
2020-12-22 English
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote
Share Issue/Capital Change
2020-12-22 French
ABIVAX: A l'approche d'étapes cliniques majeures, Abivax est retenu pour une présentation lors de la 39eme Conférence Annuelle J.P. Morgan Healthcare
Investor Presentation
2020-12-21 French
Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones
Regulatory Filings
2020-12-21 English
Abivax establishes clinical, regulatory and manufacturing framework for ABX464 phase 3 program and potential commercialization in 2021
Regulatory Filings
2020-12-09 English
Abivax complète ses plans cliniques, réglementaires et industriels en préparation du programme de phase 3 et de la commercialisation éventuelle D'ABX464 en 2021
Regulatory Filings
2020-12-09 French
Abivax calendrier de communication financière 2021
Report Publication Announcement
2020-12-03 French
Abivax 2021 Financial Communication Calendar
Report Publication Announcement
2020-12-03 English
Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
Regulatory Filings
2020-11-30 English
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 31.10.20.
Declaration of Voting Results & Voting Rights Announcements
2020-11-19 French
ABIVAX: Abivax recoit le 'Best Technology Award' aux European Mediscience Awards 2020
Regulatory Filings
2020-11-16 French
Abivax Receives 'Best Technology Award' at the European Mediscience Awards 2020
Report Publication Announcement
2020-11-16 English
Abivax annonce une présentation en webcast et téléconférence suite à l'annonce d'une augmentation de capital sursouscrite de 28 millions d'euros, sans décote
Report Publication Announcement
2020-11-02 French
Abivax announces webcast and teleconference following recent oversubscribed capital increase of EUR 28m at market price
Report Publication Announcement
2020-11-02 English
Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price
Capital/Financing Update
2020-10-29 English
Abivax annonce le succès de son augmentation de capital sursouscrite de 28 millions d'euros, sans décote
Capital/Financing Update
2020-10-29 French
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 30.09.20.
Share Issue/Capital Change
2020-10-20 French
Abivax obtient un financement non-dilutif de 15 millions d'euros auprès de Kreos Capital
Capital/Financing Update
2020-10-13 French
Abivax secures EUR 15m non-dilutive financing from Kreos Capital
Capital/Financing Update
2020-10-13 English
ABIVAX: Rapport Financier Semestriel 2020.
Interim / Quarterly Report H1 2020
2020-09-30 French
ABIVAX: Half-Year Financial Report 2020.
Interim / Quarterly Report H2 2020
2020-09-30 English
ABIVAX: Abivax annonce la mise à disposition de son rapport financier semestriel 2020
Report Publication Announcement
2020-09-30 French
Abivax announces the release of its 2020 half-year financial report
Report Publication Announcement
2020-09-30 English
Abivax présente ses résultats semestriels 2020 et fait un point d'avancement sur ses activités
Interim / Quarterly Report H2 2020
2020-09-24 French
Abivax presents first-half 2020 financial results and operations update (news with additional features)
Earnings Release H1 2020
2020-09-24 English
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 31.08.20.
Share Issue/Capital Change
2020-09-15 French
Abivax presente des resultats cliniques a long terme sur l'efficacité et la tolérance d'ABX464 après deux ans de maintenance de Phase 2a dans la rectocolite hémorragique
Earnings Release FY 2020
2020-09-02 French
ABIVAX: Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study
Regulatory Filings
2020-09-02 English
Abivax : Nombre d'actions composant le capital social et nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements
2020-09-02 French
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 30.06.20.
Share Issue/Capital Change
2020-07-21 French
ABIVAX: Bilan semestriel du contrat de liquidité au 30 juin 2020.
Capital/Financing Update
2020-07-21 French
Abivax traite un premier patient dans l'essai de Phase 2b/3 d'ABX464 dans le Covid-19
Regulatory Filings
2020-07-02 French
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Regulatory Filings
2020-07-02 English
ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 31.05.20.
Declaration of Voting Results & Voting Rights Announcements
2020-06-30 French
Abivax provides business update on most recent achievements and announces positive results of annual ordinary and extraordinary general meeting
AGM Information
2020-06-22 English
Informations privilégiées / Autres communiqués
AGM Information
2020-06-22 French
ABIVAX: Abivax receives 5m non-dilutive financing from Societe Generale as State Guaranteed Loan
Capital/Financing Update
2020-06-15 English
Rapports financiers et d'audit annuels / Rapport financier annuel
Annual Report FY 2020
2020-05-25 French
Abivax publishes universal registration document 2020 'Document d'Enregistrement Universel'
Report Publication Announcement
2020-05-25 English
Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial
Legal Proceedings Report
2020-05-25 English
URD 2020
Annual Report FY 2020
2020-05-22 French
Abivax postpones its Annual General Meeting to June 19, 2020
AGM Information
2020-05-20 English
ABIVAX: 36 million non-dilutive funding from Bpifrance for Abivax' ABX464 Covid-19 program
Share Issue/Capital Change
2020-05-15 English
ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Regulatory Filings
2020-05-14 English
Abivax postpones the publication of the yearly universal registration document ('URD')
Report Publication Announcement
2020-04-29 English
Abivax 2019 Financial Results and Operations Update (news with additional features)
Earnings Release FY 2019
2020-03-16 English
Abivax 2020 Financial Communication Calendar
Report Publication Announcement
2020-03-11 English
Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma
Regulatory Filings
2020-02-26 English
Informations privilégiées / Autres communiqués
Earnings Release FY 2020
2020-02-26 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements
2020-02-19 French
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-01-28 French
Abivax to Host Satellite Symposium at 15th Congress of the European Crohn's and Colitis Organization (ECCO) in Vienna
Regulatory Filings
2020-01-28 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change
2020-01-23 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Management Reports
2020-01-23 French
Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis
Legal Proceedings Report
2020-01-20 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-01-20 French
ABIVAX: Finanzkalender 2020
Report Publication Announcement
2020-01-20 German
Inside Information / Other news releases
Report Publication Announcement
2020-01-20 English
Informations privilégiées / Autres communiqués
Report Publication Announcement
2020-01-20 French